Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Garden Biopharmaceutical Co Change In Receivables?

Zhejiang Garden Biopharmaceutical Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Zhejiang Garden Biopharmaceutical Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Zhejiang Garden Biopharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥-36 Mil. It means Zhejiang Garden Biopharmaceutical Co's Accounts Receivable increased by ¥36 Mil from Dec. 2023 to Dec. 2024 .

Zhejiang Garden Biopharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥187 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zhejiang Garden Biopharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 52.23.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zhejiang Garden Biopharmaceutical Co's liquidation value for the three months ended in Mar. 2025 was ¥-400 Mil.

Zhejiang Garden Biopharmaceutical Co Change In Receivables Historical Data

The historical data trend for Zhejiang Garden Biopharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Garden Biopharmaceutical Co Change In Receivables Chart

Zhejiang Garden Biopharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

9.94

-47.29

-140.76

113.38

-35.70

Zhejiang Garden Biopharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Zhejiang Garden Biopharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Zhejiang Garden Biopharmaceutical Co (SZSE:300401) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zhejiang Garden Biopharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	186.804	/	326.391	*	91
=	52.23

2. In Ben Graham's calculation of liquidation value, Zhejiang Garden Biopharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Zhejiang Garden Biopharmaceutical Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1256.667	-	2193.883	+	0.75 * 186.804	+	0.5 * 794.918
=	-400

Zhejiang Garden Biopharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zhejiang Garden Biopharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Garden Biopharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Garden Biopharmaceutical Co Ltd (SZSE:300401) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 166, Street 20, Economic & Technological Development Zone, Zhejiang, Hangzhou, CHN, 310018

Website

http://www.hybiotech.com

Zhejiang Garden Biopharmaceutical Co Ltd is a China-based company. Along with its subsidiaries, the firm is engaged in the pharmaceutical manufacturing. Its business activities include research, production, and sale of vitamin D3, cholesterol, and lanolin products. Its products include lanolin alcohol pharma, lanolin alcohol cosmetic, cholesterol BP, vitamin D3 oil feed grade, vitamin D3 500 feed grade CWS, lanolin alcohol EP 200, among others.

Executives

Shao Xu Jun	Director
Liu Xiao Ping	Executives
Shao Qin Xiang	Director
Shao Jun Fang	Director
Liu Jian Gang	Directors, executives
Qian Guo Ping	Executives
Zhu Jian Xing	Supervisors
Yu Quan Heng	Directors, executives, directors
Ma Huan Zheng	Directors, executives
Li Hui Ying	Supervisors
Ma Wen De	Director
Chen Yi	Executives
Gu Yi Kang	Independent director

Zhejiang Garden Biopharmaceutical Co Headlines

No Headlines